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Abstract: Bone is an active tissue where bone mineralization and resorption occur simultaneously. 
In the case of fracture, there are numerous factors required to facilitate bone healing including 
precursor cells and blood vessels. To evaluate the interaction between bone marrow-derived 
mesenchymal stem cells (BMSC)—the precursor cells able to differentiate into bone-forming cells 
and human umbilical vein endothelial cells (HUVEC)—a cell source widely used for the study of 
blood vessels. We performed direct coculture of BMSC and HUVEC in normoxia and chemically 
induced hypoxia using Cobalt(II) chloride and Dimethyloxaloylglycine and in the condition where 
oxygen level was maintained at 1% as well. Cell proliferation was analyzed by crystal violet 
staining. Osteogenesis was examined by Alizarin Red and Collagen type I staining. Expression of 
angiogenic factor-vascular endothelial growth factor (VEGF) and endothelial marker-von 
Willebrand factor (VWF) were demonstrated by immunohistochemistry and enzyme-linked 
immunosorbent assay. The quantitative polymerase chain reaction was also used to evaluate gene 
expression. The results showed that coculture in normoxia could retain both osteogenic 
differentiation and endothelial markers while hypoxic condition limits cell proliferation and 
osteogenesis but favors the angiogenic function even after 1 of day treatment. 
Keywords: BMSC; HUVEC; normoxia; hypoxia; osteogenesis; angiogenesis 
 
1. Introduction 
Bone formation includes two important processes, namely intramembranous ossification that 
results in flat bones (bones of the face, most bones of cranium and clavicles) and endochondral 
ossification that forms long bones (tibia, femur, humerus, and radius) [1]. While the 
intramembranous process is characterized by initial differentiation of mesenchymal cells into 
osteoblasts that release osteoid (matrix composed of collagen and proteins) and then become 
osteocytes followed by blood vessel formation, endochondral pathway starts with the replacement 
of hyaline cartilage composed of chondroblasts differentiated from mesenchymal cells by 
perichondrium derived osteoblasts that secret bone matrix; in turn, this matrix prevents from the 
diffusion of the blood providing nutrients to the cartilage tissue leading to chondroblast apoptosis 
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and cartilage tissue destruction, which cause the penetration of surrounding blood vessel into free 
spaces to create medullary cavity [2]. In both processes, contribution and the close link between 
mesenchymal cells and blood vessels are crucial. In a hip replacement procedure where damaged 
femoral head and acetabulum are replaced by a metal hip inserted to the femur, bone grafts are 
sometimes required to improve osteointegration between the implant and the host’s bone. These bone 
grafts when pressed into the space between the implant and the femur, they may also attract adjacent 
osteoblasts, mesenchymal stem cells to migrate and reside in the graft. Furthermore, the existing 
blood vessels present in bone marrow carry oxygen and nutrients to the cells and possibly promote 
angiogenesis in the bone graft. Despite high vasculature, bone marrow has been considered as a 
hypoxic tissue [3,4], thus the study of osteogenesis and angiogenesis in the absence of oxygen could 
be useful to investigate the physiological state and may be utilized to create an in vitro pre-
vascularized engineered bone graft for future implantation. 
In the literature, HUVEC was found to inhibit BMSC differentiation into osteoblast in indirect 
coculture (at 1:1 ratio) [5]. On the contrary, in the 1:1 direct coculture of HUVEC and the cells with 
MSC characteristics, such as dental pulp stem cells and dental follicle derived stem cells, both 
osteogenic and angiogenic potentials are increased [6,7] respectively. According to Yamamoto et al., 
2019 [8] and Zhang et al. 2017 [9], direct coculture at the above ratio of HUVEC and BMSC also 
promotes angiogenic markers. We, therefore hypothesize that direct coculture of HUVEC and BMSC 
(1:1 ratio) may promote the generation of a pre-vascularized bone graft. 
Hypoxia-inducible factor 1 (HIF-1) activates the expression of genes related to angiogenesis 
(VEGF), erythropoiesis (EPO), and metabolism (ALDA, ENO1, LDHA, PFKL, PGK1) [10]. However, 
Gawlitta et al. 2012 [11] demonstrated that coculture of BMSC with the endothelial colony-forming 
unit as pellets in the osteogenic medium in hypoxic conditions impedes vasculogenesis of engineered 
bone. It is consistent with the findings of Griffith et al., 2009 [12] where 1% oxygen hypoxia was 
proven to decrease in vitro angiogenesis of the engineered tissue composed of HUVEC and normal 
human lung fibroblasts—a type of stromal cells. It should be noted that a hypoxic incubator cannot 
guarantee complete hypoxia as once the incubator’s door is open, the cells inside could be in contact 
with oxygen and it also requires time for the incubator to lower the oxygen back to the required level. 
Although the hypoxic chamber overcomes this drawback as the working bench and trays for placing 
cell plates are inside the hypoxic chamber, it can be limited solely for the pilot experiment. To address 
these problems, we used two reagents previously known for simulating hypoxia namely Cobalt(II) 
chloride (CoCl2) and Dimethyloxaloylglycine (DMOG) for coculture system to compare with in 
normoxia. 
In this study, we aimed to evaluate cell proliferation of BMSC and HUVEC in direct coculture 
in normoxia and hypoxia-induced by hypoxic agents. To better simulate the inflammatory condition, 
IL-1β was also added to the culture medium in normoxia. Furthermore, in vitro osteogenesis and 
angiogenesis were analyzed to determine the role of oxygen in these two processes. To our 
knowledge, this is the first study addressing the differentiation of BMSC and HUVEC in direct 
coculture system under the effect of hypoxia stimulated by chemical reagents. The findings of this 
study could be applied in the production of engineered bone grafts with osteoinductivity and pro-
angiogenic characteristics for implantation. 
2. Materials and Methods 
2.1. Cell Isolation and Culture 
2.1.1. Isolation and Expansion of BMSC 
Approval of the procedure was obtained from the Ethical Committee of IRCCS Istituto 
Ortopedico Galeazzi (Protocol v02 del 09/06/2017). Four patients undergoing hip replacement 
procedures were selected for the study with their informed consent. The patients aged between 50 
and 80 years old with a body mass index (BMI) from 18 to 30 kg/m2. None of them had a history of 
disease related to infection with HIV or HBV/HCV, bone metabolism, and joint inflammation. 
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Bone marrow aspirate from the femoral canal was collected and washed twice with 1× Phosphate 
buffer saline (PBS) at 1,700× g for 10 min at room temperature (RT). Nucleated cells were counted and 
plated at density 5 × 104 cells/cm2 in medium containing alpha minimum essential medium (αMEM, 
Thermofisher, Bleiswijk, Netherlands), 10% volume/volume (v/v) fetal bovine serum (FBS, Euroclone, 
Milan, Italy), and 1% (v/v) penicillin/streptomycin/glutamine (P/G/S, Thermofisher, Bleiswijk, 
Netherlands) supplemented with 1 ng/mL recombinant human FGF-2 (R&D Systems, Minneapolis, 
MN, USA). The primary cells were incubated in the 37 °C and 5% CO2 incubator for 1 week then the 
medium was changed twice per week. The cells were expanded up to Passage 4 (P4). We previously 
demonstrated that BMSC isolated following this protocol have typical characteristics of MSC such as 
they are devoid of hematopoietic stem cells markers (CD34, CD45) but express markers of MSC 
including CD73, CD90, and CD106; they are also able to differentiate into osteoblasts, adipocytes, and 
chondrocytes [13]. 
2.1.2. HUVEC Culture 
Three different cri-vials containing HUVEC were purchased from PromoCell (Heidelberg, 
Germany). The provider guaranteed that the cells were tested for cell marker expression of VWF, 
CD31, and Dil-Ac-LDL uptake assays and they were absent from HIV, HBV, HCV, and microbial 
contamination. The cryopreserved cells (500,000 cells/cri-vial) immediately upon arrival were plated 
on 1–10 cm dish in complete EGM2 medium composed of Endothelial cell growth medium 2 (C-
22011, PromoCell, Heidelberg, Germany) supplemented with SupplementMix (C-39211, PromoCell, 
Heidelberg, Germany). Alternatively, the complete EGM2 contains 2% (v/v) FBS, 5 ng/mL Epidermal 
Growth Factor (EGF), 10 ng/mL FGF-2, 20 ng/mL Insulin-like Growth Factor (IGF), 0.5 ng/mL VEGF 
165, 1 μg/mL ascorbic acid, 22.5 μg/mL heparin, and 0.2 μg/mL hydrocortisone. Then the cells were 
expanded in a ratio 1:4 up to P4. 
2.1.3. Coculture of BMSC and HUVEC 
The direct coculture method at ratio 1:1 was used to cultivate BMSC and HUVEC together. 
Complete EGM2 medium was utilized to initially coculture both types of cells as EGM2 could 
increase the plasticity of BMSC [14]. To mimic the inflammatory response, 100 pg/mL IL-1β (R&D 
Systems, Minneapolis, MN, USA) was added to the cell culture, its concentration used in this study 
was inferred from literature data [15]. For in vitro hypoxic conditions, either COCl2 or DMOG were 
added to the Complete medium at concentration 100 μM [16] and 0.5 mM [17], respectively. Both 
COCl2 and DMOG were purchased from Sigma (Schnelldorf, Germany). For the differentiation assay, 
besides COCl2 and DMOG, the cells in coculture were also incubated in the hypoxic chamber where 
oxygen level was maintained at 1% to compare better different hypoxic stimuli. 
2.2. Cell Proliferation Assay 
Cells for monoculture (BMSC only, HUVEC only) and coculture (BMSC + HUVEC) were plated 
at density 2,000 cells/well on 96 well plates in quintuplicate in different media which are medium 
Complete and medium Complete supplemented with either 100 pg/mL IL-1β (IL-1β) or 100 μM 
COCl2 (COCl2) or 0.5 mM DMOG (DMOG). The media were freshly changed two times per week. At 
each time point starting from day 1 to day 6, the cells were washed once with 1× PBS, stained with 
0.75% g/mL crystal violet solution for 20 min at RT, and finally washed 5 times with distilled water, 
the powder was supplied by Sigma (Schnelldorf, Germany). Photos of dried cells were taken by using 
a bright-field microscope (Leica, Wetzlar, Germany), then 100 μL of eluent solution (50% (v/v), 
absolute ethanol, and 1% (v/v) acetic acid) was added to each well to dissolve the dye absorbed by 
the cells, and absorbance was measured at 550 nm by using a microplate reader (Multiskan Ascent, 
Thermo Labsystems, Midland, Canada). 
2.3. In Vitro Osteogenic Differentiation 
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BMSC and HUVEC were cocultured in medium Complete EGM2 at following densities: 50,000 
cells/well of 24 well plate (for alizarin Red S staining and immunohistochemistry (IHC)); 300,000 
cells/well of 6 well plate for quantitative polymerase chain reaction (qPCR); 700,000 cells/10 cm dish 
for Enzyme-linked immunosorbent assay (ELISA). When the cells reached total confluence, they were 
switched to i) osteogenic medium (OM) which is EGM2 containing 2% FBS, 50 μg/mL ascorbic acid 
(Sigma, Schnelldorf, Germany)), 10mM β glycerolphosphate (Merck, Schnelldorf, Germany)) and 10−7 
M dexamethasone (Sigma, Schnelldorf, Germany)); ii) OM added 100 100 pg/mL IL-1β; iii) OM 
supplemented with 100 μM COCl2, iv) OM added 0.5 mM DMOG and v) OM in 1% O2. The addition 
of IL-1β was to evaluate osteogenesis in inflammatory conditions while the supplement of COCl2 and 
DMOG was to examine osteogenic differentiation in hypoxic conditions. Moreover, EGM2 
supplemented with 2% FBS only was used as a control (CTR) medium. The media were freshly 
changed twice per week. The experiment lasted for 9 days. 
2.4. Alizarin Red S Staining 
Alizarin Red S staining was used to observe calcium deposits formed by differentiated cells 
(osteoblasts) in osteogenic conditions. Cells were washed once with PBS, fixed in 10% formalin for 10 
min at RT, washed twice with PBS, subsequently stained in 2% (w/v) Alizarin Red S solution pH 4.2 
(the powder was supplied by Sigma, Schnelldorf, Germany) for 10 min at RT, and finally washed 
with distilled water. Photos of the plates containing dry stained cells were taken by using the scanner 
Epson V200 (Epson, Suwa, Japan). 
2.5. IHC 
The confluent cocultured cells were induced for osteogenesis in four different media as 
mentioned above. At the end of each time point (day 2 and day 9), cells were washed once with PBS, 
fixed in 10% formalin for 10 min at RT, then washed again with PBS. 0.2% Triton (Sigma, Schnelldorf, 
Germany) in PBS was added to the cells for 10 min to permeabilize the membrane. Subsequently, 
cells were incubated with 4% H2O2 for 30 min to block the endogenous peroxidase, then in 1 mg/mL 
hyaluronidase type II (Sigma, Schnelldorf, Germany) in PBS pH 6 for 15 min at 37 °C to loosen the 
matrix. Then, nonspecific blocking was performed by incubating the cells in pure FBS for 30 min at 
RT. Immediately after this blocking step, cells were incubated with 1st antibodies against VEGF 
(1:1000, ab46154, Abcam, Cambridge, UK), VWF (1:500, #65707, Cell Signaling, Beverly, MA, USA), 
and Collagen type I (1:1500, ab138492, Abcam, Cambridge, UK) for 2 h, RT. The cells were then 
washed with PBS for 3 × 5 min and incubated with biotinylated anti-rabbit secondary antibody (1:500, 
Dako Agilent, Santa Clara, CA, USA) for 30 min at RT. The 1st and 2nd antibodies were diluted in 
10% FBS in PBS. Negative control (IgG control) sample was also performed by leaving the section in 
10% FBS without 1st antibody. After being washed with PBS for 3 × 5 min, the cells were incubated 
with streptavidin horseradish peroxidase (HRP) conjugate (Dako Agilent, Santa Clara, CA, USA) for 
30 min at RT. Subsequently, the cells were washed with PBS for 3 × 5 min. For VEGF and VWF 
recognition, cells were stained with 3,3′Diaminobenzidine (DAB, Dako Agilent, Santa Clara, CA, 
USA) for 3 min and counterstained in Mayer’s hematoxylin (Sigma, Schnelldorf, Germany) for 2 min. 
For Collagen type I detection, the cells were stained with DAB-Nikel (Vector Laboratories, 
Burlingame, California, CA, USA) without the counterstaining step. Finally, the sections were 
mounted with DPX mounting medium. 
2.6. ELISA 
ELISA was used to quantify VEGF and VWF released to the media. The confluent cocultured 
cells were washed twice with sterile PBS, then the dishes were divided into three groups: 
i) Complete EGM2, Complete EGM2 + COCl2, Complete EGM2 + DMOG, Complete EGM2 in 
1% O2 
ii) CTR, CTR + COCl2, CTR + DMOG, CTR in 1% O2 
iii) OM, OM + COCl2, OM + DMOG, OM in 1% O2 
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The cells were incubated in the above media for 24 h, then were washed twice with sterile PBS 
and maintained in the medium EGM2 containing 0.1% FBS only (2 mL/10 cm dish) for another 24 h. 
Consequently, the supernatant was collected, centrifuged for 10 min at 12,000 × g at 4 °C to remove 
cell debris and stored at –20 °C. Quantification of VEGF and VWF were measured by using Human 
VEGF Quantikine ELISA kit (DVE00, R&D Systems, Minneapolis, MN, USA) and Human VWF kit 
(RAB0556, Sigma, Schnelldorf, Germany), respectively. Absorbance was read at wavelength as 
recommended instruction of the kits by using a microplate reader (Multiskan Ascent, Thermo 
Labsystems, Midland, Canada). Each sample was performed in duplicate. The experiments were 
repeated three times on three different samples. 
2.7. qPCR 
qPCR was performed to analyze the gene expression. Total RNA was isolated by using RNeasy 
Mini Kit (Qiagen, Hilden, Germany). The quality and quantity of RNA were measured by NanoDrop 
8000 (Thermo Fisher Scientific, Wilmington, DE, USA). 1 μg of RNA was reversely transcribed 
following the instruction of ImProm II reverse Transcription System (Promega, Madison, WI, USA). 
cDNA was amplified by using the PowerUp SYBR master mix (Thermofisher, Bleiswijk, Netherlands) 
on the 7500 Fast Realtime PCR System (Applied Biosystems, Waltham, MA, USA). The sequences of 
primers are listed in Table 1. The reaction plates were initially held at 50 °C for 20 s and then 95 °C 
for 10 min, subsequently, the cycling stage was performed at 95 °C for 15 s and then 60 °C for 1 min, 
this cycling stage was repeated for 40 cycles, and finally, the reactions were set at for 95 °C for 15 s, 
followed by 60 °C for 1 min, 95 °C for 30 s, and 60 °C for 15 s for the melting curve. Gene expression 
was determined according to the 2(-delta delta C(T)) method [18]. 
Table 1. Primer sequences for qPCR (F/R: forward/reverse). 
Human Gene Sequence (5′-3′) Product Size (bp) 
18S ribosomal RNA 
(18S rRNA) 
F: GTAACCCGTTGAACCCCATT 
151 
R: CCATCCAATCGGTAGTAGCG 
Collagen type IA1 
F: CAGCCGCTTCACCTACAGC 
83 
R: TTTTGTATTCAATCACTGTCTTGCC 
Alkaline phosphatase 
(ALP) 
F: ACCACCACGAGAGTGAACCA 
79 
R: CGTTGTCTGAGTACCAGTCCC 
HIF-1α 
F: CATAAAGTCTGCAACATGGAAGGT 
148 
R: ATTTGATGGGTGAGGAATGGGTT 
VEGF 
F: CTACCTCCACCATGCCAAGT 109 
 R: GCAGTAGCTGCGCTGATAGA 
VWF 
F: GCTGCTGGACACAAGTTTGA 
237 
R: ACTCATGGGGCTCTGCATAC 
2.8. Statistic Analysis 
All data are presented as means and standard error of the mean (SEM) of three independent 
experiments (n = 3). Comparisons were performed by one-way ANOVA followed by post-hoc 
Tukey’s multiple comparisons test (for ELISA analysis) or two-way ANOVA (all other data). 
Statistical analysis was performed using GraphPad Prism Version 6.0a software with statistical 
significance set at p < 0.05. 
3. Results 
3.1. Proliferation of Cells in Direct Co-Culture System 
To examine the viability and proliferation of the cells in coculture, we performed a crystal violet 
assay. The colorant stains nuclei, quantification of DNA by measuring the absorbance of stained cells 
at a specific wavelength can infer the cell number. Changes in cell morphology were well observed. 
Figure 1A shows that before the coculture experiment in the cell expansion phase, BMSC possesses a 
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fibroblast-like shape whereas HUVEC have cobblestone morphologies. Figure 1B illustrates that 
BMSC and HUVEC in monoculture in media Complete EGM2 and Complete EGM2 supplemented 
with IL-1β (IL-1β) still maintain their original morphology. In coculture in media Complete EGM2 
and IL-1β, there are more rounded cells than elongated ones in spite of the equal ratio of plating cells, 
this finding correlates with higher growth of HUVEC compared to BMSC resulting in an increased 
proliferation of cocultured cells in respect of BMSC alone (two left charts in Figure 1C). BMSC in 
hypoxia-induced by DMOG appear more circular and look healthier than HUVEC alone and 
cocultured cells under the effect of DMOG, which was confirmed by the far right chart in Figure 1C 
where the proliferation curve of BMSC reached a peak at the final time point (Day 6). Conversely, 
BMSC, when cultured alone in the condition containing COCl2, suffer from necrosis shown by 
cytoskeletal disruption, cell swelling and membrane rupture (upper second photo from the right of 
Figure 1B). However, HUVEC alone under the effect of COCl2 absorbed more the violet colorant than 
those in DMOG or BMSC alone in COCl2. Figure 1D shows the relative proliferation of cocultured 
cells in medium Complete EGM2 or Complete EGM2 supplemented with IL-1β or COCl2 or DMOG 
over time compared to day 1. While the cells in hypoxia induced by chemical agents remained almost 
at constant growth, the cells in normoxia showed an increased proliferation although there is no 
significant difference between cells in media Complete EGM2 and IL-1β. 
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Figure 1. Cell proliferation. (A) Morphology of bone marrow-derived mesenchymal stem cells 
(BMSC) and human umbilical vein endothelial cells (HUVEC) cultured in media Complete αMEM 
and Complete EGM2, respectively, for cell expansion. (B) Morphology of cells in monoculture and 
coculture in Complete EGM2 medium in the presence/absence of IL-1β or COCl2 or DMOG, scale bar 
50 μm. (C) Proliferation curve of the cells cultured in Complete EGM2 medium supplemented with 
IL-1β or COCl2 or DMOG determined by measuring the absorbance of the cells stained with crystal 
violet at 550 nm wavelength. (D) Relative proliferation of cocultured cells in different media over time 
compared to day 1. Results are the average + SEM of three experiments performed in quintuplicate 
from three different cell cultures. Lower chart demonstrates relative proliferation of cocultured cells 
over time normalized to day 1 ( p ≤ 0.0018,  p ≤ 0.0005). 
3.2. In Vitro Osteogenic Differentiation 
First, we evaluated the mineralization of cells in OM conditions in the presence or absence of IL-
1β or COCl2 or DMOG or in 1% O2 over time. Figure 2A shows the result of Alizarin Red S coloration 
demonstrating that while the cells in conditions OM formed calcium deposit starting from day 7 and 
visible at day 9, the cells in OM condition with COCl2 or DMOG or in 1% O2 did not create the deposit 
even at day 9. Deposit formation was also observed in the cells cultured in the presence of IL-1β. 
These findings were confirmed by the qPCR result in Figure 2B showing that at the early time of 
differentiation (day 2), the cells in conditions OM expressed a significantly higher level of ALP gene 
than those in OM with either COCl2 or DMOG or in 1% O2. We did not observe the significant change 
in gene expression of Runx2 (Runt-related transcription factor 2)—a key transcription factor in 
osteoblast differentiation (data not shown). There was also no significant difference in ALP 
expression between the cells in OM and IL-1β (data not shown). 
While minerals provide stiffness for bone, collagen fibers mostly collagen type I make bone 
tough and strong [19], thus we believe that evaluation of collagen type I expression is indispensable 
to analyze osteogenesis. In this experiment, we used qPCR and IHC method to detect collagen type 
I. While Figure 2B presents that gene expression of collagen type I in the cells in 1% O2 is significantly 
higher compared to that in other conditions, IHC analysis was used to observe the matrix 
organization and localization of the protein. Figure 2C shows that in monoculture, only BMSC 
expressed collagen type I (black color). Figure 2D illustrates that the cells incubated in different 
conditions over time expressed collagen type I but in a different manner. Addition of COCl2 or 
DMOG to the medium and osteogenic differentiation in 1% O2 caused the formation of a very loose 
cellular matrix, conversely, the cells absent from these two reagents created a much denser matrix 
with strong expression of collagen type I especially by the cells induced in conditions OM and OM 
supplemented with IL-1β. Moreover, Figure 2D also indicates a change in cell morphology. Cells in 
the presence of DMOG and 1% O2 seem to maintain a rounded shape even at day 9 of induction while 
the presence of COCl2 and oxygen drastically modified cells to become more elongated and smaller. 
Specifically, the cells in the conditions OM at day 9 differentiated and formed an interlaced net of 
matrix inferring cross-links of collagen fibers whereas the cell layer in conditions lacking oxygen 
displayed collagen deterioration. 
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Figure 2. In vitro osteogenesis. (A) Alizarin Red S coloration shows the accumulation of calcium 
deposit (red) of cells cocultured in control medium (CTR), osteogenic medium (OM), OM added IL-
1β or COCl2 or DMOG and OM in 1% O2 at different time points (day 0, 7, 9). (B) qPCR analysis of 
gene expression of ALP and collagen type I over time (day 0, 2, 9) in conditions OM, OM added COCl2 
or DMOG and OM in 1% O2 (n = 3,  p = 0.0156,  p < 0.0025,  p = 0.0002,  p < 0.0001). (C) IHC 
analysis illustrates Collagen type I expression (black) of BMSC and HUVEC in monoculture in 
medium Complete EGM2 at day 0 and in day 2 in media CTR, OM, OM supplemented with COCl2 
or DMOG and OM in 1% O2. Counterstaining was skipped, scale bar 50 μm. (D) IHC analysis of 
cocultured cells over time in different conditions. IgG control means the section was not incubated 
with 1st antibody, scale bar 50 μm. 
3.3. Expression of Endothelial Cell Marker and Angiogenic Factor in Osteogenic Condition 
Besides osteogenesis, we aimed to also evaluate the expression of VWF—one of the endothelial 
cell markers—and VEGF—a typical marker of angiogenesis of BMSC and HUVEC in 1:1 direct 
coculture. Figure 3A shows that in monoculture in different conditions, only HUVEC are positive to 
VWF while Figure 3B demonstrates that in coculture at day 2 VWF was expressed in all conditions 
even in media CTR and OM supplemented with IL-1β, thus it might say that HUVEC contributes to 
endothelial marker expression of cocultured cells. 
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Figure 3. Expression of endothelial cell marker—VWF. (A) IHC analysis of VWF expressed by BMSC 
and HUVEC in monoculture at day 0 in medium Complete EGM2 and at day 2 in media CTR, OM, 
OM supplemented with COCl2 or DMOG and OM in 1% O2, scale bar 50 μm, inset scale bar 25 μ m. 
(B) IHC analysis of VWF expression by cocultured cells in different conditions at day 2 and day 9, 
scale bar 50 μ m. (C) Relative gene expression of VWF shown by qPCR (n = 3,  p ≤ 0.0228,  p ≤ 
0.0057,  p = 0.0006). (D) Quantification of VWF released to the medium performed by the ELISA 
method. The cells were incubated in media Complete EGM2, CTR and OM in the presence/absence 
of COCl2 or DMOG for 24 h followed by another 24 h in the medium containing 0.1% FBS only (n = 3, 
p > 0.05). 
In coculture, at day 2, there was no remarkable difference in VWF appearance, however, at day 
9, the cells cultured under the effect of DMOG prominently depicted its presence compared to other 
conditions. qPCR was also performed to verify the gene expression of this marker by cocultured cells. 
Figure 3C shows that at day 9 the cells incubated in the presence of DMOG synthesized the highest 
level of VWF gene that correlates with IHC result, especially the difference was significant compared 
to conditions OM, OM supplemented with COCl2 and OM in 1% O2. More importantly, we observed 
that in monoculture under the effect of hypoxia caused by chemical reagents or at 1% O2 at day 9, 
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both BMSC and HUVEC suffered; however, while BMSC were still able to adhere to plastic support, 
HUVEC detached (data not shown). This observation associated with the IHC result of cocultured 
cells at day 9 shown in Figure 3B and Figure 4B may suggest that BMSC supports cell attachment in 
direct coculture. Furthermore, we performed ELISA assay to quantify VWF protein released to 
supernatant by cocultured cells after a short time (24 h) treatment. In this experiment, besides using 
OM condition, we also utilized medium Complete EGM2 and CTR added COCl2 or DMOG to exclude 
the possible effect of factors other than hypoxia-induced chemicals COCl2 and DMOG. Figure 3D 
indicates that the concentration of VWF released by the cells cultured in different conditions was 
similar. There was no significant change in VWF expression analyzed by qPCR and ELISA between 
the cells cocultured in the presence or absence of IL-1β (data not shown). 
Next, we investigated the expression of VEGF. Figure 4A illustrates that both BMSC and HUVEC 
in monoculture in different conditions over time lightly expressed VEGF. However, in coculture, 
VEGF was present showing a synergic interaction of the cocultured cells (Figure 4B). Interestingly, at 
day 2 the cells cultivated with COCl2 and DMOG strongly expressed VEGF protein, which correlates 
with PCR analysis at day 2 in Figure 4C showing an increase of the VEGF gene in the cells stimulated 
by hypoxia-induced chemicals compared to others. However, at day 9, VEGF production both in 
protein and gene level of the cells in hypoxia decreased, this contrasts with the cells maintained in 
normoxia. IHC analysis in Figure 4B indicates that VEGF expression in the cells cocultured in 1% O2 
at day 9 is less than that in other conditions that contrast with the qPCR result at the same time in 
Figure 4C. We also performed qPCR to evaluate gene expression of HIF-1α. A lower chart in Figure 
4C depicts that after 9 days in coculture the cells in 1% O2 expressed the highest level of HIF-1 α gene 
followed by the cells in DMOG. 
In addition, to fully evaluate the expression of VEGF, we also performed the ELISA method to 
quantify VEGF released into the culture supernatant. Figure 4D shows that both COCl2 and DMOG 
augmented VEGF release but DMOG has a much more striking impact. In all three groups of 
treatment conditions (Complete EGM2, CTR, and OM), DMOG led to a significant increase of VEGF 
compared to 1% O2 and COCl2 (p < 0.05). This finding could imply that in terms of using hypoxia-
induced chemicals to increase angiogenesis, DMOG could be a better option than COCl2. We also 
experimented with using IL-1β to observe the expression of VEGF, like results in osteogenesis and 
VWF expression, the addition of IL-1 β does not impede VEGF expression (data not shown). 
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Figure 4. In vitro angiogenesis. (A) IHC analysis of vascular endothelial growth factor (VEGF) 
(brown) expressed by BMSC and HUVEC in monoculture at day 0 in medium Complete EGM2 and 
at day 2 in media CTR, OM, OM supplemented with COCl2 or DMOG and OM in 1% O2, scale bar 
50 μ m. (B) IHC result of VEGF expression by the cocultured cells, scale bar 50 μm. (C) qPCR presents 
relative gene expression of VEGF and HIF 1α of the cells cocultured in media OM, OM supplemented 
with COCl2 or DMOG and OM in 1% O2 over time (n = 3,  p ≤ 0.0029,  p = 0.0004,  p < 0.0001). 
(D) ELISA data shows the concentration of VEGF released in the supernatant by the cocultured cells 
in three groups: Complete EGM2, CTR, and OM. In each group, the cells were incubated with or 
without COCl2 or DMOG and in 1% O2 for 24 h then in the medium supplemented with 0.1% FBS 
only for another 24 h (n = 3,  p < 0.05,  p < 0.01). 
4. Discussion 
Bone fracture healing of long bones is a complex and dynamic process orchestrated by three 
main phases namely inflammation, reparation and remodeling [20,21]. In inflammatory phase, blood 
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vessels carry cells of the immune system including platelets, neutrophils, and macrophages to the 
wound site, in turn, these cells are activated to release inflammatory cytokines to attract other cells. 
In the reparative step, the periosteal cells migrate and differentiate into chondrocytes at the wound 
to make callus followed by the matrix calcification, angiogenesis and substitution of chondrocytes by 
osteoblast. Finally, remodeling occurs to form compact bone and maturation of osteoblasts to 
osteoclast. Thus, the blood vessel is considered as the key element to initialize fracture healing and 
plays a critical role in cell migration, proliferation, and early differentiation. 
In total hip arthroplasty, a metal prosthesis connects the proximal femur with the acetabulum to 
replace the physiological hip function. However, over time a revision surgery may be required 
mainly due to prostheses instability and mechanical loosening [22]. In the revision procedure, 
synthetic bone grafts could be used to increase bone stock to favor integration of the host body and 
prostheses [23]. Recently, bone tissue engineering has received much interest as it uses synthetic bone 
and cells to induce osteogenesis and osteoinduction [24]. 
To increase the number of mammalian cells in vitro, scientists often incubate them in normoxia, 
which provides atmospheric oxygen level (20%–21%), however physiological oxygen in tissues falls 
in 2%–9% that can be considered as hypoxia, particularly acute hypoxia (1% O2) can exist at some 
tissues such as kidney, bone marrow, thymus [4]. It should be noted that the environment in the bone 
fracture site is hypoxic because of blood extravasation leading to interruption of oxygen supply and 
strong consummation of oxygen of cells recruited to the wound [25], thus the role of oxygen in bone 
healing should be considered. In this study, we used CoCl2 and DMOG to stimulate hypoxia. CoCl2 
inhibits von Hippel–Lindau protein (pVHL) binding to oxygen degrading domain consisting of 
proline residues of HIF-1α thus preventing HIF-1α hydroxylation by oxygen-dependent prolyl 
hydroxylases (PHD) [1,26] whereas DMOG directly inhibits PHD leading to HIF-1α stability [27,28]. 
We investigated the effect of hypoxia on cell proliferation, osteogenesis and angiogenesis in vitro 
of direct coculture system of BMSC—the progenitor cells able to differentiate into osteoblast and 
chondrocyte—and HUVEC—endothelial cells widely used for the study of blood vessel formation. 
Our findings are summarized as follows: 
1. We observed that the presence of atmospheric oxygen can promote viability and proliferation 
of cells in both monoculture and coculture, thus for expansion of BMSC and HUVEC together in 
normoxia is superior to in hypoxia. Endothelial cells in the endothelium are the first cells in contact 
with blood, thus changes in oxygen concentration of the blood could affect the cell types. Our 
evaluation of the impact of oxygen level on human BMSC proliferation is consistent with findings of 
Holzwarth et al., 2010 [17] but in contrast with Grayson et al., 2007 [29]. In this study, we used the 
complete medium containing growth factor FGF-2 for BMSC culture, Holzwarth et al., 2010 [17] used 
5% (v/v) human plasma that also consists of a cocktail of growth factors and cytokines whereas 
Grayson et al., 2007 [29] did not use any supplement of growth factors except for standard FBS. We 
hypothesize that the effect of oxygen on human BMSC proliferation is dependent on components in 
the cell culture medium. BMSC slowly grows in culture, the addition of factors required for 
proliferation provided that they maintain cell stemness should be recommended. 
2. Normoxia benefits in vitro bone formation of BMSC and HUVEC in coculture while hypoxia 
promotes angiogenesis. BMSC and HUVEC were cocultured up to full confluence then induced to 
osteogenic differentiation. Calcium deposits produced by osteoblast during mineralization are an 
indication of successful in vitro osteogenesis. In normoxia, after 9 days, the cells formed nice calcium 
deposits showed by red color after staining with Alizarin Red S whereas the cells in hypoxia did not. 
Expression of genes specific for bone formation (ALP) was also higher in normoxia than in hypoxia. 
Moreover, in both normoxia and hypoxia, we observed the appearance of collagen type I—marker of 
extracellular matrix of bone, but the matrix of the cells in normoxia was much denser particularly 
after 9 days in culture showing strong crosslinking of proteins and matrix maturation. Considering 
that collagen type I is the most abundant protein accounting for more than 90% of bone mass and 
provides tensile strength as well as load-bearing for bone connective tissue [30] thus it is 
indispensable to evaluate its expression in the study of bone formation. 
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Simultaneously with osteogenesis examination, we also investigated VWF expression of cells in 
osteogenic medium. All of the cells expressed this endothelial marker, however over time the cells 
stimulated in hypoxia indicated stronger signal. In particular, DMOG could be more efficient 
compared to CoCl2 as the cells incubated in DMOG produced more intense brown color presenting 
for VWF than CoCl2, this also correlates with the qPCR result. In addition, we discovered that short 
incubation (24 h) in hypoxia does not change the concentration of VWF released by the cells compared 
to normoxia. 
VEGF is the fundamental element of angiogenesis—new blood vessel formation from existing 
vasculature [31,32]. All of the cells incubated in both normoxia and hypoxia strongly expressed VEGF 
especially the cells stimulated by CoCl2 and DMOG after 2 days of treatment. More surprisingly, we 
discovered that after a short treatment (24 h) concentration of VEGF released into the culture 
supernatant produced by cells incubated in hypoxia surged particularly in the cells stimulated by 
DMOG, while the level of VWF released by cells remained unchanged between normoxia and 
hypoxia. Importantly, by profiling VWF and VEGF expression of the cells under the effect of two 
chemicals simulating hypoxia, we found that DMOG could be a better candidate compared to CoCl2. 
Considering that long hypoxia (more than 3 days) could hinder cell proliferation and viability, short 
hypoxia (1 day) is sufficient to push VEGF production while not affecting VWF expression and 
normoxia is critical for osteogenesis, thus to obtain both bone and blood formation, normoxia should 
be applied initially for cell culture to induce osteogenesis followed by short treatment in hypoxia to 
facilitate angiogenesis. 
3. Local inflammation is the first phase in wound healing, thus the presence of pro-inflammatory 
cytokines could be beneficial to trigger successive phases in the healing process. Thus, we used IL-1β 
to mimic the inflammatory environment. We found that the addition of IL-1 β to the medium at 100 
pg/mL concentration increased cell proliferation, did not interfere with osteogenic differentiation and 
did not alter angiogenesis of BMSC and HUVEC cocultured in normoxia. However, the level of 
cytokines must be limited otherwise systematic inflammation could occur and cause destruction of 
tissue matrix because of the production of matrix metalloproteinases (MMPs) [33,34]. This 
observation may imply that implantation of scaffolds seeded with BMSC and HUVEC in the inflamed 
joint could be possible, however further studies on other cytokines and longer time duration (more 
than 9 days) should be done. 
BMSC represents a possible application for patients suffering from musculoskeletal injuries. Our 
preliminary study showed that direct coculture of BMSC and endothelial cells at ratio 1:1 could 
maintain both osteogenesis and angiogenic potentials depending on oxygen concentration in culture, 
which could be modified by the addition of hypoxia-induced reagents. Further studies both in vitro 
and in vivo are needed to better understand the complex relationship between osteogenesis and 
angiogenesis to generate newly engineered scaffolds able to promote bone regeneration. 
Author Contributions: Conceptualization, V.T.N. and L.M.; data curation, V.T.N.; formal analysis, V.T.N.; 
funding acquisition, L.M.; investigation, V.T.N. and B.C.; methodology, V.T.N. and B.C.; project administration, 
L.M.; resources, G.M.P.; software, V.T.N.; supervision, G.M.P.; validation, F.C. and L.A.; visualization, V.T.N.; 
writing—original draft, V.T.N. and L.M.; writing—review and editing, V.T.N., B.C. and G.M.P. All authors have 
read and agreed to the published version of the manuscript. 
Funding: This research was funded by Ricerca Corrente grant of the Italian Ministry of Health. 
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the 
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to 
publish the results. 
  
Cells 2020, 9, 757 14 of 15 
 
References 
1. Kini, U.; Nandeesh, B.N. Physiology of Bone Formation, Remodeling, and Metabolism. In Radionuclide and 
Hybrid Bone Imaging; Fogelman, I., Gnanasegaran, G., van der Wall, H., Eds.; Springer Berlin Heidelberg: 
Berlin, Heidelberg, 2012; pp. 29–57 ISBN 978-3-642-02399-6. 
2. Erlebacher, A.; Filvaroff, E.H.; Gitelman, S.E.; Derynck, R. Toward a molecular understanding of skeletal 
development. Cell 1995, 80, 371–378. 
3. Parmar, K.; Mauch, P.; Vergilio, J.-A.; Sackstein, R.; Down, J.D. Distribution of hematopoietic stem cells in 
the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. USA 2007, 104, 5431–5436. 
4. Simon, M.C.; Keith, B. The role of oxygen availability in embryonic development and stem cell function. 
Nat. Rev. Mol. Cell Biol. 2008, 9, 285–296. 
5. Meury, T.; Verrier, S.; Alini, M. Human endothelial cells inhibit BMSC differentiation into mature 
osteoblasts in vitro by interfering with osterix expression. J. Cell. Biochem. 2006, 98, 992–1006. 
6. Bok, J.-S.; Byun, S.-H.; Park, B.-W.; Kang, Y.-H.; Lee, S.-L.; Rho, G.-J.; Hwang, S.-C.; Woo, D.K.; Lee, H.-J.; 
Byun, J.-H. The Role of Human Umbilical Vein Endothelial Cells in Osteogenic Differentiation of Dental 
Follicle-Derived Stem Cells in In Vitro Co-cultures. Int. J. Med. Sci. 2018, 15, 1160–1170. 
7. Dissanayaka, W.L.; Zhan, X.; Zhang, C.; Hargreaves, K.M.; Jin, L.; Tong, E.H.Y. Coculture of Dental Pulp 
Stem Cells with Endothelial Cells Enhances Osteo-/Odontogenic and Angiogenic Potential In Vitro. J. Endod. 
2012, 38, 454–463. 
8. Yamamoto, K.; Tanimura, K.; Watanabe, M.; Sano, H.; Uwamori, H.; Mabuchi, Y.; Matsuzaki, Y.; Chung, 
S.; Kamm, R.D.; Tanishita, K.; et al. Construction of Continuous Capillary Networks Stabilized by Pericyte-
like Perivascular Cells. Tissue Eng. Part A 2019, 25, 499–510. 
9. Zhang, X.; Li, J.; Ye, P.; Gao, G.; Hubbell, K.; Cui, X. Coculture of mesenchymal stem cells and endothelial 
cells enhances host tissue integration and epidermis maturation through AKT activation in gelatin 
methacryloyl hydrogel-based skin model. Acta Biomater. 2017, 59, 317–326. 
10. Semenza, G.L.; Agani, F.; Booth, G.; Forsythe, J.; Iyer, N.; Jiang, B.-H.; Leung, S.; Roe, R.; Wiener, C.; Yu, A. 
Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int. 1997, 51, 553–555. 
11. Gawlitta, D.; Fledderus, J.O.; van Rijen, M.H.P.; Dokter, I.; Alblas, J.; Verhaar, M.C.; Dhert, W.J.A. Hypoxia 
Impedes Vasculogenesis of In Vitro Engineered Bone. Tissue Eng. Part A 2012, 18, 208–218. 
12. Griffith, C.K.; George, S.C. The Effect of Hypoxia on In Vitro Prevascularization of a Thick Soft Tissue. 
Tissue Eng. Part A 2009, 15, 2423–2434. 
13. Nguyen, V.T.; Tessaro, I.; Marmotti, A.; Sirtori, C.; Peretti, G.M.; Mangiavini, L. Does the Harvesting Site 
Influence the Osteogenic Potential of Mesenchymal Stem Cells? Stem Cells Int. 2019, 2019, 1–13. 
14. Bouacida, A.; Rosset, P.; Trichet, V.; Guilloton, F.; Espagnolle, N.; Cordonier, T.; Heymann, D.; Layrolle, P.; 
Sensébé, L.; Deschaseaux, F. Pericyte-Like Progenitors Show High Immaturity and Engraftment Potential 
as Compared with Mesenchymal Stem Cells. PLoS ONE 2012, 7, e48648. 
15. Pacary, E. Synergistic effects of CoCl2 and ROCK inhibition on mesenchymal stem cell differentiation into 
neuron-like cells. J. Cell Sci. 2006, 119, 2667–2678. 
16. Groenman, F.A.; Rutter, M.; Wang, J.; Caniggia, I.; Tibboel, D.; Post, M. Effect of chemical stabilizers of 
hypoxia-inducible factors on early lung development. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2007, 293, 
L557–L567. 
17. Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR 
and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. 
18. Viguet-Carrin, S.; Garnero, P.; Delmas, P.D. The role of collagen in bone strength. Osteoporos. Int. 2006, 17, 
319–336. 
19. Baht, G.S.; Vi, L.; Alman, B.A. The Role of the Immune Cells in Fracture Healing. Curr. Osteoporos. Rep. 2018, 
16, 138–145. 
20. Oryan, A. Bone Injury and Fracture Healing Biology. Biomed Env. Sci 15. 
21. Bozic, K.J.; Kurtz, S.M.; Lau, E.; Ong, K.; Vail, T.P.; Berry, D.J. The Epidemiology of Revision Total Hip 
Arthroplasty in the United States: J. Bone Jt. Surg.- Am. Vol. 2009, 91, 128–133. 
22. Beswick, A.; Blom, A.W. Bone graft substitutes in hip revision surgery: A comprehensive overview. Injury 
2011, 42, S40–S46. 
23. Oryan, A.; Alidadi, S.; Moshiri, A.; Maffulli, N. Bone regenerative medicine: classic options, novel strategies, 
and future directions. J. Orthop. Surg. Res. 2014, 9, 18. 
Cells 2020, 9, 757 15 of 15 
 
24. Lu, C.; Saless, N.; Wang, X.; Sinha, A.; Decker, S.; Kazakia, G.; Hou, H.; Williams, B.; Swartz, H.M.; Hunt, 
T.K.; et al. The role of oxygen during fracture healing. Bone 2013, 52, 220–229. 
25. Piret, J.P.; Mottet, D.; Raes, M.; Michiels, C.; CoCl2, a chemical inducer of hypoxia-inducible factor-1, and 
hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N.Y. Acad. Sci. 2002, 973, 443–447. 
26. Yuan, Y.; Hilliard, G.; Ferguson, T.; Millhorn, D.E. Cobalt Inhibits the Interaction between Hypoxia-
inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α. J. Biol. 
Chem. 2003, 278, 15911–15916. 
27. Epstein, A.C.R.; Gleadle, J.M.; McNeill, L.A.; Hewitson, K.S.; O’Rourke, J.; Mole, D.R.; Mukherji, M.; Metzen, 
E.; Wilson, M.I.; Dhanda, A.; et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of 
Dioxygenases that Regulate HIF by Prolyl Hydroxylation. Cell 2001, 107, 43–54. 
28. Jaakkola, P.; Mole, D.R.; Tian, Y.-M.; Wilson, M.I.; Gielbert, J.; Gaskell, S.J. Targeting of HIF-alpha to the 
von Hippel–Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation. Science2001, 292, 468–
472. 
29. Holzwarth, C.; Vaegler, M.; Gieseke, F.; Pfister, S.M.; Handgretinger, R.; Kerst, G.; Müller, I. Low 
physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal 
stromal cells. BMC Cell Biol. 2010, 11, 11. 
30. Grayson, W.L.; Zhao, F.; Bunnell, B.; Ma, T. Hypoxia enhances proliferation and tissue formation of human 
mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2007, 358, 948–953. 
31. Gelse, K. Collagens—Structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 2003, 55, 1531–1546. 
32. Nilsson, M.; Heymach, J.V. Vascular Endothelial Growth Factor (VEGF) Pathway. J. Thorac. Oncol. 2006, 1, 
768–770. 
33. Mcmahon, G. VEGF Receptor Signaling in Tumor Angiogenesis. Oncologist. 2000, 5, 3–10. 
34. Fukushima, K.; Inoue, G.; Uchida, K.; Fujimaki, H.; Miyagi, M.; Nagura, N.; Uchiyama, K.; Takahira, N.; 
Takaso, M. Relationship between synovial inflammatory cytokines and progression of osteoarthritis after 
hip arthroscopy: Experimental assessment. J. Orthop. Surg. 2018, 26, 230949901877092. 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
